Psychedelic treatment for PTSD with MDMA faces misconduct hurdle : Short Wave : NPR

Folk with post-traumatic pressure weakness (PTSD) might quickly have a unused remedy possibility: MDMA.

MDMA is the chemical compound discovered within the drug often known as ecstasy. In August, the Meals and Drug Management plans to make a decision whether or not MDMA shall be licensed for marketplace in keeping with years of study. However severe allegations of study misconduct might derail the benevolence timeline.

NPR science reporter Will Stone talks to host Emily Kwong concerning the medical trials on MDMA-assisted treatment analysis and a up to date record wondering the validity of the effects.

Learn Will’s complete tale right here.

Wish to pay attention us barricade extra tales about condition analysis? E-mail us at shortwave@npr.org.

Pay attention to Shorten Tide on Spotify, Apple Podcasts and Google Podcasts.

Pay attention to each and every episode of Shorten Tide sponsor-free and help our paintings at NPR through signing up for Shorten Tide+ at plus.npr.org/shortwave.

This episode was once produced through Berly McCoy, edited through Amina Khan and reality checked through Will Stone. Josh Newell was once the audio engineer.